Imperial Innovations Group plc has invested £250,000 in Equinox Pharma Limited, a company providing advanced software products to the pharma and biopharma industry. The investment in Equinox was part of a £500,000 seed funding round, which also included a £250,000 investment from NetScientific Ltd.
Deal will be the second add-on acquisition for Danoffice since Agilitas's buyout of the company in November 2017
Bowmark will provide additional funding of £100m to fund the company's add-ons acquisitions
Exit represents an 18x return on Octopus's initial investment and a 9x return on its total investment
Deal follows M&A litigation initiated after coronavirus uncertainty and financing difficulties